Lifecore Biomedical, Inc. De annual ebitda
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2025
Lifecore Biomedical, Inc. De EBITDA Growth & History (LFCR)
Lifecore Biomedical, Inc. De's calculated EBITDA was $4.9M for fiscal 2025.
View full Lifecore Biomedical, Inc. De company overviewLifecore Biomedical, Inc. De annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 · Dec 31 | 2025-12-31 | $4.9M | — | — |
| 2025 · May 25 | 2025-05-25 | −$9.2M | −$8.3M | — |
| 2024 | 2024-05-26 | −$890,000 | $7.7M | — |
| 2023 | 2023-05-28 | −$8.6M | −$14.9M | — |
| 2022 | 2022-05-29 | $6.3M | −$4.8M | −43.23% |
| 2021 | 2021-05-30 | $11.0M | $18.1M | — |
| 2020 | 2020-05-31 | −$7.0M | −$27.7M | — |
| 2019 | 2019-05-26 | $20.7M | −$5.3M | −20.36% |
| 2018 | 2018-05-27 | $26.0M | $654,000 | +2.58% |
| 2017 | 2017-05-28 | $25.3M | $36.6M | — |
| 2016 | 2016-05-29 | −$11.2M | −$36.8M | — |
| 2015 | 2015-05-31 | $25.6M | −$1.8M | −6.42% |
| 2014 | 2014-05-25 | $27.3M | −$4.9M | −15.11% |
| 2013 | 2013-05-28 | $32.2M | $12.0M | +59.24% |
| 2012 | 2012-05-27 | $20.2M | $6.9M | +51.35% |
| 2011 | 2011-05-29 | $13.3M | $2.0M | +17.62% |
| 2010 | 2010-05-30 | $11.3M | — | — |
Lifecore Biomedical, Inc. De quarterly ebitda
Q1.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q4.15
Q1.16
Q2.16
Q3.16
Q4.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $5.1M | — | — |
| Q1 2026 | 2026-03-31 | −$2.3M | — | — |
| Q4 2025 | 2025-12-31 | $5.7M | — | — |
| Q3 2025 · Sep 30 | 2025-09-30 | −$1.1M | — | — |
| Q4 2025 | 2025-05-25 | $7.3M | $3.3M | +84.70% |
| Q3 2025 · Feb 23 | 2025-02-23 | −$7.0M | −$8.1M | — |
| Q2 2025 | 2024-11-24 | $85,000 | −$419,000 | −83.13% |
| Q1 2025 | 2024-08-25 | −$9.6M | −$3.1M | — |
| Q4 2024 | 2024-05-26 | $3.9M | $7.9M | — |
| Q3 2024 | 2024-02-25 | $1.1M | $4.4M | — |
| Q2 2024 | 2023-11-26 | $504,000 | $2.9M | — |
| Q1 2024 | 2023-08-27 | −$6.4M | −$7.5M | — |
| Q4 2023 | 2023-05-28 | −$4.0M | −$5.9M | — |
| Q3 2023 | 2023-02-26 | −$3.3M | $2.8M | — |
| Q2 2023 | 2022-11-27 | −$2.4M | −$12.0M | — |
| Q1 2023 | 2022-08-28 | $1.1M | $238,000 | +28.27% |
| Q4 2022 | 2022-05-29 | $2.0M | −$3.4M | −63.77% |
| Q3 2022 | 2022-02-27 | −$6.1M | −$11.2M | — |
| Q2 2022 | 2021-11-28 | $9.6M | $3.5M | +57.17% |
| Q1 2022 | 2021-08-29 | $842,000 | $6.3M | — |
| Q4 2021 | 2021-05-30 | $5.4M | $802,000 | +17.48% |
| Q3 2021 | 2021-02-28 | $5.1M | $15.3M | — |
| Q2 2021 | 2020-11-29 | $6.1M | $7.6M | — |
| Q1 2021 | 2020-08-30 | −$5.5M | −$5.6M | — |
| Q4 2020 | 2020-05-31 | $4.6M | −$2.6M | −36.30% |
| Q3 2020 | 2020-02-23 | −$10.2M | −$17.5M | — |
| Q2 2020 | 2019-11-24 | −$1.5M | −$4.8M | — |
| Q1 2020 | 2019-08-25 | $123,000 | −$2.8M | −95.74% |
| Q4 2019 | 2019-05-26 | $7.2M | −$4.2M | −36.85% |
| Q3 2019 | 2019-02-24 | $7.3M | $663,000 | +10.00% |
| Q2 2019 | 2018-11-25 | $3.3M | $1.0M | +45.43% |
| Q1 2019 | 2018-08-26 | $2.9M | −$2.8M | −49.15% |
| Q4 2018 | 2018-05-27 | $11.4M | $6.9M | +155.50% |
| Q3 2018 | 2018-02-25 | $6.6M | −$419,000 | −5.95% |
| Q2 2018 | 2017-11-26 | $2.3M | −$3.5M | −60.70% |
| Q1 2018 | 2017-08-27 | $5.7M | −$2.3M | −29.19% |
| Q4 2017 | 2017-05-28 | $4.5M | −$4.7M | −51.26% |
| Q3 2017 | 2017-02-26 | $7.0M | $38.5M | — |
| Q2 2017 | 2016-11-27 | $5.8M | $879,000 | +17.81% |
| Q1 2017 | 2016-08-28 | $8.0M | $1.9M | +30.45% |
| Q4 2016 | 2016-05-29 | $9.2M | $1.0M | +12.86% |
| Q3 2016 | 2016-02-28 | −$31.5M | −$38.1M | — |
| Q2 2016 | 2015-11-29 | $4.9M | −$787,000 | −13.75% |
| Q1 2016 | 2015-08-30 | $6.1M | $1.1M | +21.81% |
| Q4 2015 | 2015-05-31 | $8.1M | $1.1M | +15.02% |
| Q3 2015 | 2015-03-01 | $6.7M | −$4.6M | −41.06% |
| Q2 2015 | 2014-11-30 | $5.7M | $601,000 | +11.74% |
| Q1 2015 | 2014-08-31 | $5.0M | $1.2M | +32.19% |
| Q4 2014 | 2014-05-25 | $7.1M | — | — |
| Q3 2014 | 2014-02-23 | $11.3M | $2.8M | +32.66% |
| Q2 2014 | 2013-11-24 | $5.1M | −$7.8M | −60.30% |
| Q1 2014 | 2013-08-25 | $3.8M | −$1.0M | −21.42% |
| Q3 2013 | 2013-02-24 | $8.5M | $3.1M | +57.37% |
| Q2 2013 · Nov 25 | 2012-11-25 | $12.9M | $7.3M | +131.02% |
| Q1 2013 | 2012-08-26 | $4.9M | $631,000 | +14.92% |
| Q4 2012 | 2012-05-27 | $5.0M | — | — |
| Q3 2012 | 2012-02-26 | $5.4M | — | — |
| Q2 2012 | 2011-11-27 | $5.6M | — | — |
| Q1 2012 | 2011-08-28 | $4.2M | −$1.0M | −19.30% |
| Q1 2011 | 2010-08-29 | $5.2M | — | — |
Lifecore Biomedical, Inc. De ebitda trends
Between the periods ended 2010-05-30 and 2025-12-31, Lifecore Biomedical, Inc. De's ebitda decreased from $11.3M to $4.9M, a change of −$6.4M. The latest reported quarter, Q2 2026, shows $5.1M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lifecore Biomedical, Inc. De source filings ↗Community posts
Webster agrees Lifecore buyout with cash and contingent payments
Lifecore Biomedical ($LFCR) has agreed to be acquired by a Webster Equity Partners affiliate. Common shareholders would receive $6.28 in cash per share at closing, a 49.5% premium to the preceding trading day’s close, plus a non-tradable co ...
